Skip to content
AwardedSpainGoods

Adquisición de Nirsevimab frente al virus respiratorio sincitial.

Published
Published 5 September 2025

Overview

El objeto del contrato consiste en la adquisición de 2.100 dosis de nirsevimab con el fin de cubrir las necesidades de los servicios sanitarios para poder cumplir con la administración de dicho medicamento en la población perteneciente a los grupos de riesgo, con la siguiente distribución: - 800 dosis de Nirsevimab 100 mg/0,5 mL inyectable, para su administración a niños con un peso mayor de 5 kilogramos. - 1.300 dosis de Nirsevimab 50 mg/1mL inyectable, para su administración a niños con un peso menor de 5 kilogramos.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
5 September 2025
Classification (CPV)
Pharmaceutical productsVaccines

Award outcome

Awarded value
€438,900
Award date
29 August 2025
Contract period
— → 31 December 2025
Winner
  • SANOFI-AVENTIS S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    5 September 2025

Contracting authority

  • Gobierno de La Rioja

    Procuring entity

    Logroño, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Adquisición de Nirsevimab frente al virus respiratorio sincitial. — won by SANOFI-AVENTIS S.A. — Skim